Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Outokumpu increases its financial target on EBITDA run-rate improvement

Outokumpu OyjStock exchange releaseNovember 4, 2021 at 8.55 am EETOutokumpu increases its financial target on EBITDA run-rate improvement Outokumpu launched a new strategy in November 2020 and set financial targets by the end of 2022. The targets included an EBITDA run-rate improvement by EUR 200 million and a reduction of the net debt to EBITDA ratio to below 3.0. The company has made strong progress in its strategy execution. With a commitment to continue de-risking the company by the end of 2022, Outokumpu increases its initial EBITDA run-rate improvement target from EUR 200

Invitation to the presentation of Elekta’s second quarter 2021/22

SWEDEN, November 4, 2021 – Elekta (EKTA-B.ST) invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25. The interim report for the second quarter will be published at 7:30 a.m. CET on the same day. The company’s development will be presented by Elekta’s President and CEO, Gustaf Salford, together with CFO, Johan Adebäck. After the presentation, held in English, a Q&A session will follow. The presentation will be broadcast live on the web. It will be necessary to join the phone conference if you plan to ask questions. A recording

HKScan’s EBIT stable, profit improvement continued in Finland and Sweden

HKScan Corporation, January-September Interim Report, 4 November 2021 at 8.30 a.m. Finnish timeHKScan’s Interim Report 1 January – 30 September 2021  HKScan’s EBIT stable, profit improvement continued in Finland and Sweden July-September 2021 · HKScan’s net sales totalled EUR 446.8 (438.3) million. Clear growth in retail sales of own branded products continued. Sales clearly increased particularly in the product categories with higher added value, such as meals and meal components. Food service sales increased as a result of the gradual removal of restrictions related to the

GARO will publish its report for the third quarter 2021 at 08.30 CEST on Thursday, November 11.

GARO will publish its report for the third quarter 2021 at 08.30 CEST on Thursday, November 11. Conference call at 09.30 CESTThe company will host a conference call for the financial community at 09.30 CEST the same day. The conference will be hosted by Patrik Andersson, President & CEO and Helena Claesson, Chief Financial Officer. Dial in numbers:Sweden: 010 884 8016All other locations: +44 20 3936 2999Participant Access Code: 45 59 87  The presentation material will be published at www.garo.se prior to the conference call. The conference will also be audio webcasted in “

Kid ASA - Third Quarter 2021 Results

Lier, 4 November 2021: The board of Directors of Kid ASA has approved the financial report for the third quarter of 2021.Q3 2021 was the 6th consecutive quarter with year-on-year increased Earnings Per Share for the Kid Group with high profitability, driven by continued revenue growth, maintained gross margins and stringent cost control. Key financial highlights · Revenues increased by 3.6% and like-for-like growth increased by 0.1%. Compared to Q3 2019, like-for-like sales increased by +17.4% · Gross margin decreased by 1.7 percentage points to 61.4%, driven by increased B2B

Storskogen acquires Special Wheels

Storskogen has entered into an agreement to acquire Specialfälgar i Kungsbacka Holding AB (Special Wheels). Special Wheels is a wheel supplier in the Nordics for passenger cars and commercial vehicles. The company reported a turnover of 317 MSEK in 2020 and reports continued strong growth in 2021 with high profitability. Storskogen expects to complete the acquisition in the beginning of December 2021.Special Wheels is a designer and supplier of wheels and accessories to passenger cars and commercial vehicles, mainly through the proprietary brands Nitro Wheels and Image Wheels. The company

Save the Date: Nordic Nanovector ASA to host in-person and virtual R&D Day on 30 November 2021

Oslo, Norway, 4 November 2021 Nordic Nanovector ASA (OSE: NANOV), a clinical stage biotechnology company developing targeted radiopharmaceuticals to extend and improve the lives of patients with haematological cancers, will host an R&D Day on Tuesday, 30 November 2021 at 14:00 CET/ 13:00 GMT/ 08:00 ET. The meeting will be held in person in Oslo and will also be available via live webcast. The meeting, intended for investors and analysts, will provide an overview of the Company’s vision, progress to date, development pipeline and corporate strategy. Presentations will be delivered

Teleste 1-9/2021: Adjusted operating result on par with the reference period, net sales decreased, component availability restricted deliveries, strong growth in orders received.

TELESTE CORPORATION         INTERIM REPORT 4 NOVEMBER 2021 AT 8:30 EET TELESTE CORPORATION INTERIM REPORT 1 JANUARY TO 30 SEPTEMBER 2021 ADJUSTED OPERATING RESULT ON PAR WITH THE REFERENCE PERIOD, NET SALES DECREASED, COMPONENT AVAILABILITY RESTRICTED DELIVERIES, STRONG GROWTH IN ORDERS RECEIVED July-September 2021 - Net sales amounted to EUR 32.3 (35.7) million, a decrease of 9.5%- Adjusted operating result was EUR 2.3 (2.2) million, an increase of 2.6%- Operating result amounted to EUR 2.3 (2.2) million, an increase of 2.6%- Earnings per share, including discontinued

Pihlajalinna Plc’s financial reporting and AGM in 2022

Pihlajalinna Plc                           Stock Exchange Release          4 November 2021 at 8:25 a.m. Pihlajalinna Plc’s financial reporting and AGM in 2022 Pihlajalinna will publish its financial information in 2022 as follows: · Financial statements bulletin 2021: Friday, 18 February 2022 · Financial statements and Board of Directors’ report: no later than in week 12 · Interim report January–March: Thursday, 5 May 2022 · Half-year financial report January–June: Friday, 12 August 2022 · Interim Report January–September: Friday, 4 November 2022 The Annual General

Hexagon strengthens European footprint. Opens new commercial center in Munich with focus on in-market OEM Tier 1 support

Hexagon Composites, a global leader in clean energy solutions for transportation, opened a new commercial center in Munich, Germany, on November 4, 2021. Strategically located close to Europe’s largest auto producers, major European original equipment manufacturers (OEMs) and fleet operators, the move expands Hexagon’s in-market customer support in coordination with manufacturing capacity expansion. A “one-stop-shop” for clean energy solutions, the center facilitates a large spectrum of Hexagon’s portfolio from Hexagon Agility’s compressed (renewable) natural gas solutions to Hexagon

Targovax ASA – Notice of extraordinary general meeting – Fully underwritten rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE The board of directors of Targovax ASA ("Targovax" or the "Company") has resolved to propose that the Company carries out a share capital increase, by way of a fully underwritten rights issue, to raise gross proceeds

Pihlajalinna Interim Report 1 January–30 September 2021 (9 months)

Pihlajalinna Plc                          Interim Report              4 November 2021 at 8:00 a.m. Pihlajalinna Interim report 1 January–30 September 2021 (9 months) Revenue continued to increase, profitability improvedThe figures in this interim report are unaudited. The comparison figures in brackets refer to the corresponding period in the previous year. A brief look at July-September: · Revenue amounted to EUR 140.6 (123.9) million – an increase of EUR 16.8 million, or 13.5 per cent · Adjusted EBITDA was EUR 18.8 (17.2) million – an increase of 9.2 per cent ·

Camurus’ Interim Report Third Quarter 2021

“Solid third quarter with continued progress in our development pipeline, double-digit quarterly sales growth and strong results development” Summary third quarter 2021 July - September · Total revenue amounted to SEK 154 (100) million, an increase of 54% (54% at CER[1]), whereof product sales were SEK 152 (94) million, an increase of 61% (62% at CER) · Quarterly sales growth was 11% (12% at CER) compared to previous quarter · Operating result was SEK -6 (-23) million, an increase of 73% · Cash position at the end of the quarter was SEK 426 (476) million · Buvidal®

BERGENBIO ASA: INVITATION TO THIRD QUARTER 2021 RESULTS PRESENTATION AND WEBCAST

Bergen, Norway, 4 November 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will be announcing its results for the third quarter 2021 on Tuesday 16 November 2021. The briefing will take place at 10:00 am CET at: Carnegie AS, Fjordalleen 16, Aker Brygge, 5th Floor, Oslo where BerGenBio’s senior management team will provide an update on the Company followed by a Q&A session. To attend in person please register by mail to hanna.haug@carnegie.no The presentation will webcast

Veidekke ASA: To build the world’s best rainy-day school

Veidekke has been commissioned to build Torslandaskolan F-6 for the Gothenburg City authority. The design and build contract has a value of approx. SEK 217 million. The new school is scheduled for completion in spring 2024.The City of Gothenburg is currently celebrating its 400th anniversary, and the construction of Torslandaskolan F-6 is part of the anniversary initiative “Rain Gothenburg”. Under the slogan "The best city in the world when it’s raining", Gothenburg focuses on sustainability and addressing climate change. Torslandaskolan aims to make water a resource for play as well as for

Northern Horizons: A Pathway for Scotland to Become a Clean Energy Exporter

A vision to utilise Scottish offshore wind resources in the North Sea to make the country an exporter of clean energy has been unveiled at the COP 26 climate change conference in Glasgow.The Northern Horizons Project has been unveiled by Aker Horizons’ portfolio companies Aker Offshore Wind and Aker Clean Hydrogen, who have the technical know-how and expertise to realise the project, and DNV, the independent energy expert and assurance provider. The project describes how harnessing 10GW of renewable energy in the North Sea can deliver decarbonisation targets by sending clean products to

Invitation to telephone conference in connection with Green Landscaping Group quarterly report January-September 2021

Green Landscaping Group publishes its report for the third quarter 2021 on November 11 at 07:00 CEST.CEO Johan Nordström and CFO Carl-Fredrik Meijer will present the report and answer questions during a telephone conference with a web presentation on November 11 at 10:00 CEST. Participants dial in: Telephone: SE: +46 850558352 UK: +44 3333009272 US: +1 6319131422 (US PIN: 44576681#)Webcast: https://financialhearings.com/event/41646   The presentation will be held in English.

Ambea’s interim report July – September 2021

Strong quarter with growing demand. CEO comment:A look back on the third quarter confirms that occupancy and demand in elderly care in Sweden is continuing to rise. We can also see how social challenges such as demographic shifts, a lack of care placements and mental illness are once again becoming evident. How society will be affected in the long term by this difficult period we have experienced is anybody’s guess, but we are now seeing some consequences with impact on Ambea’s operational areas. Mental health problems have increased in the community, while the expansion of new

Caverion Corporation’s Interim Report for 1 January – 30 September 2021

Caverion Corporation Interim Report 4 November 2021 at 8.00 a.m. EETCaverion Corporation’s Interim Report for 1 January – 30 September 2021 Continued improvement in profitability and strong increase in order backlog 1 July – 30 September 2021 · Revenue: EUR 493.7 (515.5) million, down by 4.2 percent, 4.9 percent in local currencies. Organic growth was-4.6 percent. Services business revenue decreased by 0.1 percent, 0.8 percent in local currencies. · Adjusted EBITDA: EUR 35.0 (34.8) million, or 7.1 (6.8) percent of revenue. · Adjusted EBITA: EUR 21.5 (21.2) million, or 4.4

UNION therapeutics receives FDA Fast Track designation for oral orismilast for the treatment of moderate to severe atopic dermatitis

· FDA’s Fast Track designation for oral orismilast underscores the urgent need for new treatment option with potential to fulfil the unmet medical needs for people affected by atopic dermatitis (AD) · AD is the most common chronic inflammatory skin disease in the developed world · Orismilast is a next generation PDE4 inhibitor with broad anti-inflammatory properties also in development for the treatment of psoriasis and hidradenitis suppurativa (HS) Hellerup, Denmark, 4 November 2021 – UNION therapeutics A/S, a privately-held, multi-asset, clinical stage, pharmaceutical company

Sedana Medical AB (publ), Third Quarter Report 2021

Sedaconda (isoflurane) approved in 11 European marketsThird quarter 2021 · Net sales totalled SEK 28 M (21), equivalent to an increase of 32% compared to the third quarter of 2020. At constant exchange rates, sales increased by 34% with all regions showing positive growth. · Gross profit was SEK 19 M (13), equivalent to a margin of 68% (62). The improved margin is primarily an effect of lower transportation costs, favorable product mix and timing effects. · Earnings before interest, taxes, depreciation, and amortisation (EBITDA) totalled SEK -14 M (-10), equivalent to an EBITDA

Targovax ASA: Third quarter 2021 results

Oslo, Norway, 4 November 2021 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its third quarter 2021 results. Targovax’s CEO will give an online presentation and update on the clinical program to investors, analysts and the press at 10:00 CET today (details below).THIRD QUARTER HIGHLIGHTS · Received acceptance of two posters to be presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in November · Presented poster at European Society for Medical Oncology (ESMO)

Kojamo plc’s Interim Report 1 January–30 September 2021

Kojamo plc Stock Exchange Release 4 November 2021 at 8:00 a.m. EETKojamo plc’s Interim Report 1 January–30 September 2021 Total revenue increased, the fair value of investment properties was EUR 7.6 billion This is a summary of the January–September Interim Report, which is in its entirety attached to this release and can be downloaded from the company’s website at www.kojamo.fi/investors. Unless otherwise stated, the comparison figures in brackets refer to the corresponding period of the previous year. The figures in this Interim Report have not been audited. Summary of July–

There are no items matching the current filter
There are no more items matching the current filter
Back to top